Penserra Capital Management LLC Macrogenics Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$15.91 - $21.88 $22,274 - $30,632	-1,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $690 - $1,004	35 Added 2.56%	1,400 $29,000
Q2 2021 Aug 12, 2021	BUY	$20.49 - $35.63 $1,946 - $3,384	95 Added 7.48%	1,365 $36,000
Q1 2021 May 13, 2021	SELL	$18.99 - $33.2 $759 - $1,328	-40 Reduced 3.05%	1,270 $40,000
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $16,420 - $21,996	846 Added 182.33%	1,310 $29,000
Q3 2020 Nov 13, 2020	BUY	$24.69 - $31.6 $11,456 - $14,662	464 New	464 $11,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.